152 related articles for article (PubMed ID: 38308767)
1. Investigating the role of tumour-to-skin proximity in predicting nodal metastasis in breast cancer.
Sivakanthan T; Tanner J; Mahata B; Agrawal A
Breast Cancer Res Treat; 2024 May; 205(1):109-116. PubMed ID: 38308767
[TBL] [Abstract][Full Text] [Related]
2. Mode of presentation and skin thickening on ultrasound may predict nodal burden in breast cancer patients with a positive axillary core biopsy.
Choong WL; Evans A; Purdie CA; Wang H; Donnan PT; Lawson B; Macaskill EJ
Br J Radiol; 2020 Apr; 93(1108):20190711. PubMed ID: 31971817
[TBL] [Abstract][Full Text] [Related]
3. Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
Di Micco R; Zuber V; Fiacco E; Carriero F; Gattuso MI; Nazzaro L; Panizza P; Gianolli L; Canevari C; Di Muzio N; Pasetti M; Sassi I; Zambetti M; Gentilini OD
Eur J Surg Oncol; 2019 Jun; 45(6):969-975. PubMed ID: 30744944
[TBL] [Abstract][Full Text] [Related]
4. Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer.
Al-Hattali S; Vinnicombe SJ; Gowdh NM; Evans A; Armstrong S; Adamson D; Purdie CA; Macaskill EJ
Cancer Imaging; 2019 Dec; 19(1):91. PubMed ID: 31878958
[TBL] [Abstract][Full Text] [Related]
5. Axillary Nodal Burden Assessed with Pretreatment Breast MRI Is Associated with Failed Sentinel Lymph Node Identification after Neoadjuvant Chemotherapy for Breast Cancer.
Kim WH; Kim HJ; Park CS; Lee J; Park HY; Jung JH; Kim WW; Chae YS; Lee SJ; Kim SH
Radiology; 2020 May; 295(2):275-282. PubMed ID: 32125253
[TBL] [Abstract][Full Text] [Related]
6. Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011.
Boland MR; Prichard RS; Daskalova I; Lowery AJ; Evoy D; Geraghty J; Rothwell J; Quinn CM; O'Doherty A; McDermott EW
Eur J Surg Oncol; 2015 Apr; 41(4):559-65. PubMed ID: 25648466
[TBL] [Abstract][Full Text] [Related]
7. Does Alternative and Traditional WASAM (Local cautery) Therapy Facilitate an Early and More Extensive Locoregional Metastasis of Breast Cancer?
Department of Surgery and National Oncology Center, The Royal Hospital Muscat, Sultanate of Oman
Gulf J Oncolog; 2016 Sep; 1(22):37-42. PubMed ID: 28191804
[TBL] [Abstract][Full Text] [Related]
8. Distance of breast cancer from the skin and nipple impacts axillary nodal metastases.
Ansari B; Morton MJ; Adamczyk DL; Jones KN; Brodt JK; Degnim AC; Jakub JW; Lohse CM; Boughey JC
Ann Surg Oncol; 2011 Oct; 18(11):3174-80. PubMed ID: 21861233
[TBL] [Abstract][Full Text] [Related]
9. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
10. Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
Dihge L; Ohlsson M; Edén P; Bendahl PO; Rydén L
BMC Cancer; 2019 Jun; 19(1):610. PubMed ID: 31226956
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
12. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.
Verheuvel NC; Ooms HW; Tjan-Heijnen VC; Roumen RM; Voogd AC
Breast; 2016 Jun; 27():175-81. PubMed ID: 27123958
[TBL] [Abstract][Full Text] [Related]
13. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy.
Anderson TL; Glazebrook KN; Murphy BL; Viers LD; Hieken TJ
Eur J Radiol; 2017 Apr; 89():163-168. PubMed ID: 28267534
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer patients with a negative axillary ultrasound may have clinically significant nodal metastasis.
Keelan S; Heeney A; Downey E; Hegarty A; Roche T; Power C; Mhuircheartaigh NN; Duke D; Kerr J; Hambly N; Hill A
Breast Cancer Res Treat; 2021 Jun; 187(2):303-310. PubMed ID: 33837870
[TBL] [Abstract][Full Text] [Related]
16. Assessment of preoperative axillary nodal disease burden: breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy.
Reis J; Boavida J; Tran HT; Lyngra M; Reitsma LC; Schandiz H; Melles WA; Gjesdal KI; Geisler J; Geitung JT
BMC Cancer; 2022 Jun; 22(1):702. PubMed ID: 35752785
[TBL] [Abstract][Full Text] [Related]
17. Preoperative axillary lymph node evaluation in breast cancer patients by breast magnetic resonance imaging (MRI): Can breast MRI exclude advanced nodal disease?
Hyun SJ; Kim EK; Moon HJ; Yoon JH; Kim MJ
Eur Radiol; 2016 Nov; 26(11):3865-3873. PubMed ID: 26843011
[TBL] [Abstract][Full Text] [Related]
18. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
19. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
[TBL] [Abstract][Full Text] [Related]
20. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
